Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 29 January 2025.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
This page offers advice to patients who are feeling sick.
-
Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.
File results
-
FOI/2024/0490 - Continuous pre-emptive flow model for A&E patients
-
FOI/2024/0491 - Breast cancer treatment
-
FOI/2024/0492 - Maternity consultant-led births/ obstetric theatre
-
FOI/2024/0495 - Voice, data and network - LAN, WLAN, data centre, WAN/ internet connectivity, SIP, telephony, teams phone system, contact centre
-
FOI/2024/0496 - Outpatient procedures for 2023/24
-
FOI/2024/0502 - GP/A&E appointments/ deaths from overdose of weight loss drugs Saxenda/ ozempic/ wegovy
-
FOI/2024/0503 - Frozen food preparation methods
-
FOI/2024/0506 - Permanent/ fixed-term/ international recruitment
-
FOI/2024/0509 - Structure chart for Estates and Facilities
-
FOI/2024/0511 - Radiotherapy treatment planning system/artificial intelligence (AI)/ costs